Advanced CANCER Therapies

life is precious

Striving for a better future Silenseed is dedicated towards developing
novel drugs that target personalized treatment for solid tumors.
Harnessing new scientific horizons we develop solutions for both   
untreated cancers and innovative ways for (RNAi) drug delivery. 

Revolutionary cancer therapies

icon doctor

Clinical Trial's

Phase II Clinical Trial for Pancreatic Cancer –
Currently Available for stage 3 patients 
For more details


RNAI delivery

Motivated by the challenges facing RNAi delivery, Silenseed has developed a novel drug delivery platform LODER™ which enables the insertion of RNAi therapeutic pharmaceuticals directly into the core of solid tumors


Patient Care

With patients in mind – Silenseed is dedicated towards developing novel drugs that harness new scientific horizons developing solutions for untreated cancers 


Inside Silenseed

Inside Silenseed

Clinical Updates

KRAS-LODER Reaches Undrugable Targets